The Fondation pour la Recherche Médicale label awarded to Nicolas Venteclef’s team
We are pleased to share that Nicolas Venteclef’s team, Immunity and Metabolism of Diabetes (IMMEDIAB), has been awarded the prestigious FRM team label, a mark of scientific excellence from the Fondation pour la Recherche Médicale, in recognition of the project’s high scientific value and potential impact on metabolic disease research.